Simultaneous measurement of tadehaginoside and its principal metabolite in rats by HPLC–MS/MS and its application in pharmacokinetics and tissue distribution study

References

• Amalan V, Vijayakumar N, Indumathi D, Ramakrishnan A. 2016. Antidiabetic and antihyperlipidemic activity of p-coumaric acid in diabetic rats, role of pancreatic GLUT 2: in vivo approach. Biomed Pharmacother. 84:230–236.
   PubMed Web of Science ®Google Scholar
• Aye MM, Aung HT, Sein MM, Armijos C. 2019. A review on the phytochemistry, medicinal properties and pharmacological activities of 15 selected myanmar medicinal plants. Molecules. 24(2):293.
   PubMed Web of Science ®Google Scholar
• Azuma K, Ippoushi K, Nakayama M, Ito H, Higashio H, Terao J. 2000. Absorption of chlorogenic acid and caffeic acid in rats after oral administration. J Agric Food Chem. 48(11):5496–5500.
   PubMed Web of Science ®Google Scholar
• Bhateria M, Ramakrishna R, Puttrevu SK, Yerrabelli S, Saxena AK, Bhatta RS. 2016. Pre-clinical investigation of plasma pharmacokinetics and biodistribution of a novel antithrombotic agent S002-333 in mice using LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 1031:154–162.
   PubMed Web of Science ®Google Scholar
• Chamberlain CA, Rubio VY, Garrett TJ. 2019. Impact of matrix effects and ionization efficiency in non-quantitative untargeted metabolomics. Metabolomics. 15(10):1–9.
   Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. 2015. Pharmacopoeia of the People’s Republic of China. Beijing (China): China Medical Science Press.
   Google Scholar
• Day AJ, Mellon F, Barron D, Sarrazin G, Morgan MRA, Williamson G. 2001. Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res. 35(6):941–952.
   PubMed Web of Science ®Google Scholar
• Jakutiene E, Grikiniene J, Vaitkevicius A, Tschaika M, Didziapetriene J, Stakisaitis D. 2007. Sodium valproate stimulates potassium and chloride urinary excretion in rats: gender differences. BMC Pharmacol. 7(1):1–7.
   PubMedGoogle Scholar
• Li YX, Zhang YQ, Yang T, Li H, Guo J, Zhao QQ, Xie JB. 2015. Pharmacokinetics and tissue distribution study of isovitexin in rats by HPLC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 991:13–20.
   PubMed Web of Science ®Google Scholar
• Liu HF, Yang JL, Du FF, Gao XM, Ma XT, Huang YH, Xu F, Niu W, Wang FQ, Mao Y, et al. 2009. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab Dispos. 37(12):2290–2298.
   PubMed Web of Science ®Google Scholar
• Liu Z, Martin J, Orme L, Seddon B, Desai J, Nicholls W, Thomson D, Porter D, McCowage G, Underhill C, et al. 2018. Gender differences in doxorubicin pharmacology for subjects with chemosensitive cancers of young adulthood. Cancer Chemother Pharmacol. 82(5):887–898.
   PubMed Web of Science ®Google Scholar
• Maison T, Ruttanaphan T, Pipattanaporn P, Chuawong P, Bullangpoti V, Pluempanupat W. 2014. Antifeedant activity of crude extracts from stems and leaves of Tadehagi triquetrum (L.) Ohashi and seeds of Phaseolus lathyroides against Helicoverpa armigera Hubner (Lepidoptera: Noctuidae). Commun Agric Appl Biol Sci. 79(2):233–238.
   PubMedGoogle Scholar
• Millecam J, De Baere S, Croubels S, Devreese M. 2019. In vivo metabolism of ibuprofen in growing conventional pigs: a pharmacokinetic approach. Front Pharmacol. 10:712.
   PubMed Web of Science ®Google Scholar
• Ramakrishna R, Bhateria M, Puttrevu SK, Prasad YD, Singh R, Bhatta RS. 2016. A liquid chromatography-tandem mass spectrometry method for the quantitation of actarit in rabbit plasma: application to pharmacokinetics and metabolic stability. J Mass Spectrom. 51(1):69–78.
   PubMed Web of Science ®Google Scholar
• Tang AC, Chen XY, Lu QY, Zheng N, Wei YF, Wu XY. 2014. Antihepatotoxic effect of tadehaginoside, extracted from Tadehagi triquetrum (L.), against CCl4-lesioned rats through activating the Nrf2 signaling pathway and attenuating the inflammatory response. Inflammation. 37(4):1006–1014.
   PubMed Web of Science ®Google Scholar
• Tao Y, Huang SR, Yan JZ, Cai BC. 2019. Pharmacokinetic study of six triterpenoids of raw and processed Alisma plantago-aquatica in rat plasma by using ultra performance liquid chromatography-tandem mass spectrometry approach. J Chromatogr B Analyt Technol Biomed Life Sci. 1124:323–330.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. 2001. Center for Drug Evaluation and Research (CDER). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf
   Google Scholar
• Wang S, Zhang XP, Li X, Liu QB, Zhou Y, Guo P, Dong ZQ, Wu CM. 2019. Phenylpropanoid glucosides from Tadehagi triquetrum inhibit oxLDL-evoked foam cell formation through modulating cholesterol homeostasis in RAW264.7 macrophages. Nat Prod Res. 33(6):893–896.
   PubMed Web of Science ®Google Scholar
• Wu JN, Zhang CY, Zhang TT, Zhao D, An N, Li YB, Zhu NL, Wang S, Chen F, Zhang XP. 2015. A new lignan with hypoglycemic activity from Tadehagi triquetrum. Nat Prod Res. 29(18):1723–1727.
   PubMed Web of Science ®Google Scholar
• Zabad OM, Samra YA, Eissa LA. 2019. p-Coumaric acid alleviates experimental diabetic nephropathy through modulation of Toll like receptor-4 in rats. Life Sci. 238:116965.
   PubMed Web of Science ®Google Scholar
• Zhang X, Chen C, Li Y, Chen D, Dong L, Na W, Wu C, Zhang J, Li Y. 2016. Tadehaginosides A–J, phenylpropanoid glucosides from Tadehagi triquetrum, enhance glucose uptake via the upregulation of PPARγ and GLUT-4 in C2C12 myotubes. J Nat Prod. 79(5):1249–1258.
   PubMed Web of Science ®Google Scholar
• Zhang XP, Li HL, Tan YF, Lai WY, Chen F. 2015. Identification of tadehaginoside and its metabolites in rat plasma using LC-MS/MS with selected reaction monitoring. J Hainan Medical Univ. 21:145–147.
   Google Scholar
• Zhang XP, Wang S, Li YH, Zhao D, An N, Wu JN, Zhang TT, Wu CM, Li YB. 2015. Tadehaginoside modulates lipogenesis and glucose consumption in HepG2 cells. Nat Prod Res. 29(24):2287–2290.
   PubMed Web of Science ®Google Scholar